2007
DOI: 10.1016/j.ijpharm.2007.01.039
|View full text |Cite
|
Sign up to set email alerts
|

In vitro evaluation of calcium binding capacity of chitosan and thiolated chitosan poly(isobutyl cyanoacrylate) core–shell nanoparticles

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
36
0

Year Published

2010
2010
2023
2023

Publication Types

Select...
7
1
1

Relationship

0
9

Authors

Journals

citations
Cited by 64 publications
(38 citation statements)
references
References 29 publications
2
36
0
Order By: Relevance
“…Recently Bravo-Osuna and co-workers have proposed several approaches to elaborate the application of thiolated CS by preserving its mucoadhesive property and permeation-enhancing ability. They have utilised the emulsion polymerization method to prepare thiolated CS-NPs coated with poly-isobutylcyanoacrylate (110)(111)(112)(113). They evaluated the impact of different formulation factors like the effect of molecular weight and CS-thiobarbituric acid ratio for surface modification.…”
Section: Thiolated Chitosanmentioning
confidence: 99%
See 1 more Smart Citation
“…Recently Bravo-Osuna and co-workers have proposed several approaches to elaborate the application of thiolated CS by preserving its mucoadhesive property and permeation-enhancing ability. They have utilised the emulsion polymerization method to prepare thiolated CS-NPs coated with poly-isobutylcyanoacrylate (110)(111)(112)(113). They evaluated the impact of different formulation factors like the effect of molecular weight and CS-thiobarbituric acid ratio for surface modification.…”
Section: Thiolated Chitosanmentioning
confidence: 99%
“…It can be said that these orally administered CS-NPs are still in their early stage of pre-clinical evaluation and would require further investigation before being considered for evaluation in humans. So far, most of the results obtained are based on in vitro (49,52,110,(132)(133)(134)(135) and ex vivo (74,77,78) studies. Although some pre-clinical studies for CS-NPs (oral, parenteral etc.)…”
Section: Current Perspective Of Chitosan Nanoparticles For Clinical Usementioning
confidence: 99%
“…Many nonspecific enzymes, namely, cellulases, lipases and proteases, or specific enzymes chitosanases, have been used to prepare COS (Thadathil and Velappan 2014). The 10 kDa or less COS have been found lots of biological activities owe to their structures and physicochemical properties (Xia et al, 2011), such as hypocholesterolemic (Kim and Rajapakse, 2005), antimicrobial Kim, 2000, 2001), immunity-enhancing and anticancer effects (Xia et al, 2011), accelerating calcium and iron absorption (Bravo-Osuna et al, 2007), antioxidant (Je et al, 2004;Mendis et al, 2007;Fang et al, 2013) and so on. However, relatively little is known about the effects and mechanism of COS on the vase life of cut roses.…”
Section: Introductionmentioning
confidence: 99%
“…In recent years, numerous studies have been carried out to investigate the synthesis and the application of polysaccharide-based self-aggregate nanoparticles as drug delivery systems. Generally, these hydrophobic molecules can be divided into linear [184,185], cyclic hydrophobic molecules [186,187], polyacrylate family [188,189], etc.…”
Section: Self-assembly Polysaccharide Nanoparticlesmentioning
confidence: 99%